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One year of Clinical Ophthalmology
Welcome to the ﬁ  nal edition of Clinical Ophthalmology in 2007. This edition contains 
the usual range of topics that illustrate the breadth and depth of ophthalmology and 
visual sciences. This is what we were aiming for when starting this journal and we 
hope this is how you have found it. One of the other original aims of the journal – that 
of representing an international audience – can also be seen to be well illustrated in 
this present edition.
Current papers range from superb, erudite clinical reviews such as ‘Telemedicine 
Diagnosis and Management’ by Eugene Helveston (2007), ‘Pharmacologic Therapies 
for Diabetic Retinopathy and Diabetic Macular Edema’ by Alon Harris (2007), to 
‘Ganciclovir ophthalmic gel, 0.15%: a valuable tool for treating ocular herpes’ by 
Joseph Colin (2007). State of the art basic science research is represented in articles 
such as ‘Recent advances of corneal regeneration and possible application of embry-
onic stem (ES) cell derived corneal epithelial cells’ by Suzuki (2007). We continue 
to publish case reports as these can give useful insights into clinical issues such as 
‘Candida Endophthalmitis: A critical diagnosis in the critically ill’ by Kelly and col-
leagues (2007).
One area of publication not represented in the current edition of the journal is a 
correspondence section. This is not perhaps surprising as it is the ﬁ  rst year of publica-
tion but it is something we would always wish to encourage. Letters are a sign of a 
living, vibrant journal that readers actively want to get involved with. 
Correspondence can be of various types. Some letters add their own viewpoint to 
articles published – sometimes in agreement and sometimes putting an alternative point 
of view. In either case, we would always give the original author a right of reply. A 
correspondent may point out an error in a paper and we would publish this in the next 
edition of Clinical Ophthalmology (again seeking to solicit the views of the original 
author prior to publication). The corpus of medical knowledge is a precious thing and 
journals must seek to publish as high quality information as possible. As scientiﬁ  c 
‘truth’ is not ﬁ  xed but changes over time, this change needs to be quickly reﬂ  ected 
in journals. It is the dynamism of a journal – its desire and ability to rapidly publish 
alternative views – that is the best way to protect and enhance medical knowledge. 
Ultimately, it is of course the readers who, by their own expertise, are the true 
guardians of this knowledge. We hope therefore that you will contact me if you feel 
you have something to add to any paper we publish in forthcoming editions of the 
journal. Whether you have anything to add or not, we hope you will continue to enjoy 
Clinical Ophthalmology. 
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